SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to an earnings beat and optimistic guidance for vehicle deliveries, particularly with strong anticipation for its R2 SUV launch, while community discussions remain divided between excitement for its future and skepticism about profitability amidst broader EV sector challenges.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toast Inc. is trending following a post-earnings sell-off driven by an adjusted EPS miss, despite reporting a revenue beat and robust recurring revenue growth. Community discussion is rife with "burnt toast" memes and criticism of previous bullish recommendations, contrasting with long-term investors who highlight the company's strong market position in restaurant technology amid broader "AI killing software" concerns.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending following a strong 30-year Treasury auction that demonstrated robust demand for long-term bonds, driving community discussion around a potential shift to lower yields and heightened anticipation for upcoming CPI data and Federal Reserve policy.

Wynn Resorts Ltd. is a holding company, which engages in the design, development, and operation of destination casino resorts. It operates through the following segments: Wynn Palace, Wynn Macau, Las Vegas Operations, Encore Boston Harbor, and Corporate and Other. The company was founded by Stephen Alan Wynn, Elaine P. Wynn, and Kazuo Okada in 2002 and is headquartered in Las Vegas, NV.

Wynn Resorts Ltd.

Wynn Resorts is trending following its recent earnings report, which disappointed investors with weaker performance from its Las Vegas operations. The community is actively discussing the earnings miss, debating the broader impact on the stock while acknowledging ongoing recovery trends in Macau and future growth initiatives.

Mega Fortune Co., Ltd. operates as an investment holding company. It specializes in delivering comprehensive IoT solutions and services across various industries. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune Company Limited (MGRT) is experiencing an extreme price and volume surge with multiple trading halts, prompting intense community discussion about its nature as a low-float "Chinese IPO." Many traders view it as a highly speculative pump-and-dump play, drawing comparisons to other volatile stocks known for rapid, unsustainable gains.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul C. Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest shares are plummeting after reporting a Q4 earnings miss and conservative Q1 guidance, fueling a sharp divide within the community regarding its future as a value play or an acquisition target, especially amidst recent layoffs and a strategic pivot to AI.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is trending due to rapid ecosystem expansion, including new DeFi integrations like Kalshi and Orbs Perpetuals, which are driving significant user growth and total value locked (TVL). The community is highly bullish on its performance as a high-throughput Layer-1 blockchain, with discussions focused on its EVM compatibility, high staking yields, and resilience during market dips, seeing it as a strong contender with explosive growth potential.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP CRYPTO) is a major talking point as its price continues a challenging downtrend, leading to frustration among some investors while others aggressively "buy the dip" due to its near-max 10 million token supply. The community is actively discussing the Compound Foundation's performance, the anticipation of V4, and its potential in the Real World Assets (RWA) space.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy`s Co

Wendy's is trending with investors sharply divided ahead of its Q4 earnings report, as a significant price drop and high dividend yield fuel speculation of undervaluation and a potential short squeeze or buyout, while others remain cautious due to ongoing CEO uncertainty and broader sector challenges.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

The restaurant chain Jack In The Box is trending amid widespread community concerns over its substantial debt and the recent significant loss from divesting Del Taco, driving strong bearish sentiment and bankruptcy predictions. However, a vocal contingent also highlights its high short interest and growing activist investor stake as potential catalysts for a short squeeze or turnaround.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Positive Forecast for Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price

HC Wainwright upped their target price on Agios Pharmaceuticals from $62.00 to $65.00 and gave the company a "buy" rating in a report on Thursday...

Agios Pharmaceuticals (NASDAQ:AGIO) Posts Earnings Results, Beats Expectations By $0.11 EPS

Agios Pharmaceuticals (NASDAQ:AGIO - Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.85) earnings per share for the quarter, topping...

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of +6.25% and +94.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Recommendation of "Hold" from Analysts

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) has earned an average rating of "Hold" from the eleven analysts that are currently covering the stock, MarketBeat.com reports. One research...

Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Agios Pharmaceuticals (AGIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Agios Pharmaceuticals (AGIO) Projected to Post Earnings on Thursday

Agios Pharmaceuticals (NASDAQ:AGIO) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 12. (View Earnings Report at...

Williams to Report Q4 Earnings: What Surprise Awaits Investors?

WMB is set to report Q4 earnings on Feb. 10, with analysts expecting a 21% jump in profit and a 14% rise in revenues.

Q2 EPS Estimate for Agios Pharmaceuticals Boosted by Analyst

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Analysts at Zacks Research boosted their Q2 2026 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research report...

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twelve research firms that are presently covering the firm, Marketbeat...

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). In a filing disclosed on January 12th, the Representative disclosed that...

$AGIO Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$1.85 down -7.56% YoY
• Reported revenue of $19.97M up 86.09% YoY
• Agios expects its $1.2B cash balance, product revenue, and interest income to fund the U.S. launch of AQVESME, prepare for mitapivat&#39;s potential U.S. launch in sickle cell disease, and advance clinical programs.

Stocktwits

Agios Pharmaceuticals Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$1.85 down -7.56% YoY
• Reported revenue of $19.97M up 86.09% YoY
• Agios expects its $1.2B cash balance, product revenue, and interest income to fund the U.S. launch of AQVESME, prepare for mitapivat's potential U.S. launch in sickle cell disease, and advance clinical programs.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

With earnings season underway and rate-cut expectations shifting, the next move in the S&P 500 could set the tone for 2026. Are bulls still in control, or is volatility about to pick up? Cast your vote.

AGIO
Agios Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AGIO News

AGIOAgios Pharmaceuticals Inc